Product Information

DORZOLAMIDE-TIMOLOL 2-0.5%(PF) is a generic product labeled by Aurobindo Pharma Limited, priced at $1.1320 per EA under NDC 65862094760. Its NADAC has been published 396 times since Jan 23, 2019.

FDA first approved this application on Jul 24, 2018. Its Orange Book therapeutic-equivalence code is AT2.

DORZOLAMIDE-TIMOLOL 2-0.5%(PF)

Dorzolamide Hydrochloride and Timolol Maleate Preservative Free
$1.1320per EA

Strength

20; 5 mg/mL; mg/mL

NDC

65862094760

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207630

FDA Approved

7/24/2018

TE Code

AT2

On Market Since

7/24/2018

Pharmacological Classes

Adrenergic beta-Antagonists
Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors
beta-Adrenergic Blocker

Price Statistics

The NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has been published 396 times since Jan 23, 2019, and over the history we have for it it has declined 49.0%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1320 per EA
All-time high$2.2200 (Feb 13, 2019)
All-time low$0.9746 (Nov 20, 2024)
52-week high$1.1462
52-week low$1.0471
Median price$1.7427
Average price$1.6279
Largest weekly change+40.7% (Jun 19, 2024)
Weeks tracked396
Tracking sinceJan 23, 2019

Price History

1W

+2.5%

1M

+2.5%

3M

+4.8%

6M

+8.1%

1Y

-1.2%

3Y

-22.0%

5Y

-36.7%

All

-49.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dorzolamide Hydrochloride and Timolol Maleate Preservative Free market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?

The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE-TIMOLOL 2-0.5%(PF), manufactured by Aurobindo Pharma Limited, is $1.1320 per EA (NDC 65862094760), effective Aug 19, 2026.

How has the price of DORZOLAMIDE-TIMOLOL 2-0.5%(PF) changed over time?

Over the history we have for it, the NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has declined 49.0%. It has been tracked across 396 weekly CMS publications since Jan 23, 2019.

What are the highest and lowest recorded NADAC prices for DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?

Since Jan 23, 2019, the NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has ranged from a low of $0.9746 (Nov 20, 2024) to a high of $2.2200 (Feb 13, 2019), with a median of $1.7427 per EA.

Are there cheaper alternatives to DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?

No other NADAC-published product currently shares the active ingredient and strength of DORZOLAMIDE-TIMOLOL 2-0.5%(PF) in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?

DORZOLAMIDE-TIMOLOL 2-0.5%(PF) (NDC 65862094760) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.